Ann Riggs
Family Medicine · Newton, KSNPI 1124099072
Payments from drug & device makers
Across 100 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$365
- Lilly USA, LLC$204
- Teva Pharmaceuticals USA, Inc.$176
- Takeda Pharmaceuticals U.S.A., Inc.$135
- AstraZeneca$134
- Boehringer Ingelheim$122
- plus $519 from 16 others
What the payments were for
- Food & beverage$1,655100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $365 |
| Lilly USA, LLC | 11 | $204 |
| Teva Pharmaceuticals USA, Inc. | 6 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $135 |
| AstraZeneca | 9 | $134 |
| Boehringer Ingelheim | 7 | $122 |
| Supernus Pharmaceuticals, Inc. | 7 | $108 |
| Astellas Pharma US Inc | 3 | $66 |
| Novo Nordisk | 3 | $60 |
| Pfizer | 3 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Adlon Therapeutics L.p. | 2 | $26 |
| Johnson & Johnson | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Shire North American Group Inc | 1 | $14 |
| Antares Pharma, Inc. | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$1,655 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 12 | $6,993 |
| OxycontinOxycodone Hcl | 12 | $6,972 |
| Nebivolol Hcl | 13 | $1,065 |
| Drospirenone-Ethinyl EstradiolEthinyl Estradiol/Drospirenone | 15 | $564 |
| Sertraline Hcl | 19 | $529 |
| Pantoprazole Sodium | 36 | $476 |
| Atorvastatin Calcium | 67 | $471 |
| Levothyroxine Sodium | 92 | $460 |
| Oxycodone Hcl | 27 | $302 |
| Propranolol Hcl | 13 | $282 |
| Losartan Potassium | 50 | $274 |
| Alprazolam | 27 | $267 |
| Trazodone Hcl | 17 | $261 |
| Duloxetine Hcl | 32 | $231 |
| Metoprolol Succinate | 19 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $134 | $6,99312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.
Other family medicine in Newton
- Richard GloverNewton$19.6M
- Troy HoldemanNewton$3.2M
- Stacy SlechtaNewton$3M
- Robyn HartvicksonNewton$2M
- Terry PolingWichita$24.2M
- Daniel DickersonLenexa$13.6M
- Patrick YaoOlathe$11.7M
- Michael RauschAugusta$8.1M
- Terry KleinWichita$5.9M
- Richard EgelhofWichita$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.